Democritus University of Thrace (DUTH)
Ανάπτυξη και έλεγχος εγκυρότητας στατιστικών προγνωστικών μοντέλων ειδικής και ολικής επιβίωσης με τη μέθοδο κατασκευής νομογραμμάτων (nomograms) και ανάλυσης καμπύλης αποφάσεων (decision curve analysis), σε ασθενείς με σαρκωματοειδές ουροθηλιακό καρκίνωμα της ουροδόχου κύστεως
Abstract
dc:descriptionΙntroduction: Sarcomatoid urothelial carcinoma (SUC) is a rare and aggressive variant of bladder cancer with limited data guiding prognosis. In this study, we present the first prognostic nomograms in the literature for the 3- and 5-year overall survival (OS) and disease-specific survival (DSS), for patients with SUC derived from the surveillance, epidemiology and end results database (SEER). Materials and methods: Patients with SUC were identified by using the ICD-10 topography codes C67.0-C67.9 (bladder cancer), and the morphologic code 8122 (SUC). Patients were randomly divided into a training cohort (TC) and a validation cohort (VC) (7:3 ratio). Variables significantly associated with OS and DSS were identified with multivariate Cox regression and backwards stepwise conditional approach; each variable received “risk points” according to its beta coefficient, based on the formula: Probability of an event at time t=S0(t)exp(β1x1, β2x2...), (β = regression coefficients, x = observed covariate values, S0(t) = survival function). Cumulative risk points were assigned to each patient and four distinct risk categories for OS and DSS were constructed. Harrel’s optimism-corrected C-statistic with bootstrap resampling and calibration curves were used to assess discriminatory performance in the training and validation cohort. Discriminatory performance of the model was compared to the AJCC 8th edition with the Akaike information criterion. Goodness of fit between the nomograms and the AJCC 8th edition staging system was compared with the Akaike Information Criterion (AIC). Results: A total of 741 patients with SUC were included (507 TC, 234 VC). No statistically significant differences in baseline characteristics were identified between the two cohorts. Sex, SEER stage, radical cystectomy and chemotherapy were common variables for the OS and the DSS nomograms with the addition of age in the former. Optimism-corrected C-statistic for the nomograms was 0.68 and 0.67 for OS and DSS respectively. In comparison, C-statistic for AJCC was 0.59 for OS and 0.60 for DSS. AIC values demonstrated superior prognostic performance for the nomogram, compared to the AJCC system. Calibration curves constructed for the nomograms showed appropriate consistency between predicted and actual survival. The nomograms demonstrated optimal clinical utility in the DCA, outperforming the AJCC staging system, by maintaining a higher clinical net benefit than treat all, treat none and AJCC curves, across threshold probabilities. The nomograms demonstrated lower AIC values, and thus better prognostic utility, compared to the AJCC system. Conclusion: We present the first prognostic nomograms developed in patients with SUC. Our models demonstrated superior prognostic performance to the AJCC system, by utilizing a set of variables readily available in daily practice and may serve as useful tools for the individualized risk assessment of these patients.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Diamantopoulos, Leonidas-Nikolaos
- Διαμαντόπουλος, Λεωνίδας-Νικόλαος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61749